Sphingolipids in cancer
著者
書誌事項
Sphingolipids in cancer
(Advances in cancer research / edited by George Klein and Sidney Weinhouse, v. 140)
Academic Press, an imprint of Elsevier, 2018
大学図書館所蔵 全6件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
内容説明・目次
内容説明
Sphingolipids in Cancer, Volume 140, the latest release in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research. Topics discussed in this updated volume include Mechanisms of ceramide-dependent cancer cell death, Sphingolipids as regulators of autophagy and endocytic trafficking, The role and function of sphingomyelin biosynthesis in the development of cancer, Neutral sphingomyelinases in cancer: Friend or foe?, Sphingolipid rendezvous at the crossroad of NAFLD and senescence, Ceramide signaling and p53 pathways, Sphingolipid regulation of RNA Biology in cancer phenotypes, The role of ceramide-1-phosphate in tumor cell survival and dissemination, and more.
目次
1. Mechanisms of ceramide-dependent cancer cell deathRose Nganga, Natalia Oleinik and Besim Ogretmen 2. Sphingolipids as regulators of autophagy and endocytic traffickingMegan M. Young and Hong-Gang Wang3. Role and function of sphingomyelin biosynthesis in the development of cancerGiovanni D'Angelo, Sitapriya Moorthi and Chiara Luberto4. Neutral sphingomyelinases in cancer: friend or foe?Christopher J. Clarke5. Ceramide and exosomes: a novel target in cancer biology and therapyAhmed Elsherbini and Erhard Bieberich6. Sphingolipids at the crossroads of NAFLD and senescenceMariana Nikolova-Karakashian7. Ceramide signaling and p53 pathwaysKristen Jeffries and Natalia Krupenko8. The role of ceramide 1-phosphate in tumor cell survival and disseminationAntonio Gomez-Munoz9. The onus of sphingolipid enzymes in cancer drug resistanceSamy A.F. Morad and Myles C. Cabot10. Interdiction of sphingolipid metabolism revisited: focus on prostate cancerChristina Voelkel-Johnson, James S. Norris and Shai White-Gilbertson11. Targeting sphingosine kinases for the treatment of cancerClayton S. Lewis, Christina Voelkel-Johnson and Charles D. Smith12. Novel sphingolipid-based cancer therapeutics in the personalized medicine eraJeremy Shaw, Pedro Costa-Pinheiro, Logan Patterson, Kelly Drews, Sarah Spiegel and Mark Kester13. Side effects in cancer therapy: are sphingolipids to blame?Falak Patel and Stefka D. Spassieva
「Nielsen BookData」 より